CD37, Human (Otlertuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD37, Human (Otlertuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD37, Human (Otlertuzumab biosimilar)
CloneOtlertuzumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeVH-V kappa-CH2-CH3
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, IP, FCM, FuncS, Neut, IF, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD37 Recombinant Antibody (Otlertuzumab). Otlertuzumab (TRU- 016) is a humanized monoclonal antibody that targets CD37 designed for the treatment of cancer. This drug was developed by Emergent BioSolutions and has been in clinical trails for lymphoma and Chronic Lymphocytic Leukemia (CLL).
Immunogenn/a
Other NamesAnti-CD37 Recombinant Antibody, Research Grade Otlertuzumab, Anti-Human CD37 Recombinant Antibody(Otlertuzumab), TRU-016, Antibody Drug Analogues, Monoclonal Antibody, YR1329, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1372645-37-8
Catalog #YR1329
Priceplease inquire
Order / More InfoCD37, Human (Otlertuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.